Worldwide appointed as preferred CRO provider for Diurnal

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Pinkypills)
(Image: Getty/Pinkypills)
Diurnal has named Worldwide Clinical Trials as its preferred clinical services provider ahead of its planned Phase III study which is expected to begin later this year.

The Morrisville, NC-headquartered contract research organization (CRO) Worldwide Clinical Trials (Worldwide) will initially support the US clinical development of Diurnal’s cortisol replacement product, Chronocort.

Diurnal CEO Martin Whitaker, PhD, said the US represents an estimated total market opportunity of approximately $1bn billion for Chronocort in both congenital adrenal hyperplasia (CAH) and adrenal insufficiency (AI).

The planned Phase III study will recruit up to 150 patients with CAH and is expected to halfway through the year.

Worldwide will also conduct a Phase II study of Chronocort in AI patients. The study is expected to launch around the end of 2018.

Related news

Show more

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 15-Aug-2022 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Planning Your First-In-Human Trial

Planning Your First-In-Human Trial

Altasciences | 15-Jul-2022 | Technical / White Paper

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug. A successfully conducted FIH trial provides...

Related suppliers

Follow us


View more